Open-label, Randomized, Crossover Study to Compare the Bioavailability of One Coated Tablet of Opxion (Levonorgestrel 1.5 mg From Bayer de Mexico) vs. Two Tablets of Postday (Levonorgestrel 0.75 mg From Investigacion Farmaceutica), in Healthy Volunteers.

Trial Profile

Open-label, Randomized, Crossover Study to Compare the Bioavailability of One Coated Tablet of Opxion (Levonorgestrel 1.5 mg From Bayer de Mexico) vs. Two Tablets of Postday (Levonorgestrel 0.75 mg From Investigacion Farmaceutica), in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2011

At a glance

  • Drugs Levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Pharmacokinetics
  • Acronyms LEVEQ-1
  • Sponsors Bayer
  • Most Recent Events

    • 05 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top